Atlas Trials

SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research

Clinical trial NCT04844125 · COMPLETED

Trial details

NCT number
NCT04844125
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Hypercholesterolemia
Start date
2021-04-14
Primary completion
2022-08-12
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.